Increased interleukin-1 and interleukin-1 receptor antagonist levels in cervical mucus in the ovulatory phase in comparison with the follicular phase.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Gynecologic and Obstetric Investigation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000291847PMID 9127129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Asymptomatic Bacteriospermia in Infertile Men *

  2009cited by this paper
• Interleukin‐1 receptor antagonist expression in epithelial cells of human endometrium

  1995cited by this paper
• Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.

  1992cited by this paper
• Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes.

  1992cited by this paper
• Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.

  1992cited by this paper
• Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid.

  1992cited by this paper
• A specific receptor antagonist for interleukin 1 prevents Escherichia coli‐induced shock in rabbits

  1991cited by this paper
• Interleukin-1 and interleukin-1 antagonism.

  1991cited by this paper
• Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats

  1991cited by this paper
• A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

  1991cited by this paper
• Interleukin-1 inhibits in vitro decidualization of human endometrial stromal cells.

  1991cited by this paper
• Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

  1990cited by this paper
• Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

  1990cited by this paper
• Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.

  1990cited by this paper
• Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.

  1990cited by this paper
• Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

  1990cited by this paper
• Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

  1990cited by this paper
• Upper and lower reproductive tract bacteria in 126 women with acute pelvic inflammatory disease. Microbial susceptibility and clinical response to four therapeutic regimens.

  1988cited by this paper
• Interleukin-1: a possible role in the infertility associated with endometriosis.

  1987cited by this paper
• A urine inhibitor of interleukin 1 activity that blocks ligand binding.

  1987cited by this paper
• Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors.

  1987cited by this paper
• Recovery of microorganisms in semen and relationship to semen evaluation.

  1986cited by this paper
• In vitro production of interleukin 1 by normal and malignant human B lymphocytes.

  1986cited by this paper
• Increased plasma interleukin-1 activity in women after ovulation.

  1985cited by this paper
• Stimulation of interleukin-1 production from placental monocytes.

  1984cited by this paper

• Cytokine response following perturbation of the cervicovaginal milieu during HPV genital infection

  2021cites this paper
• Novel three dimensional human endocervix cultures respond to 28-day hormone treatment.

  2015cites this paper
• Evaluation of a multiplex panel of immune‐related markers in cervical secretions: A methodologic study

  2014cites this paper
• The role of the cervix in fertility: is it time for a reappraisal?

  2014cites this paper
• Association of Cytokine Gene Polymorphisms in COPD Patients

  2012cites this paper
• Association of cytokine gene polymorphisms in patients with chronic obstructive pulmonary disease.

  2012cites this paper
• Immunological and physicochemical properties of cervical ovulatory mucus.

  2010cites this paper
• The Existence of Gender Difference in IL-1Ra Gene Polymorphism

  2007cites this paper
• Detection of implantation-related cytokines in cervicovaginal secretions and peripheral blood of fertile women during ovulatory menstrual cycles.

  2004cites this paper
• Increased tumor necrosis factor-alpha in whole blood during the luteal phase of ovulatory cycles.

  2004cites this paper
• CHAPTER 28 – Interleukin-1 receptor antagonist [IL-1F3]

  2003cites this paper
• Influence of interleukin-1 receptor antagonist gene polymorphism on disease.

  2002cites this paper
• Polymorphism of IL-1 receptor antagonist gene: role in cancer.

  2002cites this paper
• Spielt VEGF bei den zyklischen Zervixveränderungen eine Rolle?

  2001cites this paper
• Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle.

  1999cites this paper